Dr. Jessy Dana Dorn Ph.D. Net Worth

Dr. Jessy Dana Dorn Ph.D. biography

Dr. Jessy Dana Dorn Ph.D. is the VP of Clinical & Scientific Affairs at Vivani Medical Inc.

What is the salary of Dr D?

As the VP of Clinical & Scientific Affairs of Vivani Medical Inc, the total compensation of Dr D at Vivani Medical Inc is $233,988. There are 5 executives at Vivani Medical Inc getting paid more, with Jonathan McGuire having the highest compensation of $1,225,100.

How old is Dr D?

Dr D is 45, he's been the VP of Clinical & Scientific Affairs of Vivani Medical Inc since . There are 12 older and no younger executives at Vivani Medical Inc. The oldest executive at Vivani Medical Inc is Aaron Mendelsohn, 67, who is the Independent Director.

What's Dr D's mailing address?

Jessy's mailing address filed with the SEC is 12744 SAN FERNANDO ROAD, SUITE 400, SYLMAR, CA, 91342.

Insiders trading at Vivani Medical Inc

Over the last 10 years, insiders at Vivani Medical Inc have traded over $9,497,123 worth of Vivani Medical Inc stock and bought 22,269,890 units worth $31,710,900 . The most active insiders traders include Alfred E Mann, Gregg Williams a E. Mann Living Trust Incume.... On average, Vivani Medical Inc executives and independent directors trade stock every 31 days with the average trade being worth of $1,432,564. The most recent stock trade was executed by Gregg Williams on 13 June 2022, trading 3,800 units of EYES stock currently worth $7,600.

What does Vivani Medical Inc do?

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California.

Vivani Medical Inc executives and stock owners

Vivani Medical Inc executives and other stock owners filed with the SEC include:

• Jonathan McGuire,
  Director
• Stephen Okland,
  Chief Commercial Officer
• Stephen D. Okland Jr.,
  Chief Strategy & Bus. Devel. Officer
• Edward Randolph,
  Vice President - Manufacturing
• Scott Dunbar,
  Acting Chief Exec. Officer
• Dr. Jessy Dana Dorn Ph.D.,
  VP of Clinical & Scientific Affairs
• Edward David Randolph,
  VP of Operations
• Edward Jonathon Sedo,
  Acting Chief Accounting Officer & Principal Financial Officer
• Aaron Mendelsohn,
  Independent Director
• Ted Randolph,
  Vice President - Operations
• Matthew Pfeffer,
  Acting Chief Executive Officer, Director
• Gregg Williams,
  Chairman of the Board
• Lisa M. Wilson,
  Founder & Pres of In-Site Communications and Investor Relations for Second Sight
• Gunnar Bjorg,
  Founder
• Thomas B Miller,
  Chief Financial Officer
• E. Mann Living Trust Incume...,
  
• Gregoire Cosendai,
  VP of European Operations
• William J Phd Link,
  Director
• David Murray Jacques,
  VP-Research Development
• John T Blake,
  Chief Financial Officer
• William Patrick Ryan,
  Chief Operating Officer
• Jessy Dana Dorn,
  VP-Clin & Scientific Affairs
• John Anthony Moses,
  Commercial VP Americas
• Robert J. Greenberg,
  Chief Executive Officer
• Alfred E Mann,
  Director
• Anne Marie Juliette Ripley,
  VP Regulatory Affairs